ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 465

MRI Bone Erosion at Baseline Predicts the Subsequent Radiographic Progression in Early-Stage RA Patients Who Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort

Mami Tamai1, Yoshikazu Nakashima1, Kazuhiko Arima2, Junko Kita1, Masataka Umeda1, Shoichi Fukui1, Ayako Nishino1, Takahisa Suzuki1, Yoshiro Horai1, Akitomo Okada3, Tomohiro Koga1, Shin-ya Kawashiri1,2, Naoki Iwamoto1, Kunihiro Ichinose1, Satoshi Yamasaki4, Hideki Nakamura1, Tomoki Origuchi5, Kiyoshi Aoyagi2, Masataka Uetani6, Katsumi Eguchi7 and Atsushi Kawakami1, 1Department of Immunology and Rheumatology, Nagasaki University, Nagasaki, Japan, 2Department of Public Health, Nagasaki University, Nagasaki, Japan, 3Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan, 4Hiroshima University, Hiroshima, Japan, 5Department of Rehabilitation Sciences, Nagasaki University, Nagasaki, Japan, 6Department of Radiology and Radiation Research, Nagasaki University, Nagasaki, Japan, 7Department of Rheumatology, Sasebo Chuo Hospital, Sasebo, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: MRI, prognostic factors, remission and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Given the improved detection of joint injury by MRI than by clinical examination, EULAR recommendations for the use of imaging of the joints in the clinical management of RA states that MRI is useful in monitoring disease activity. However, there are few clinical investigations searching whether MRI findings are even helpful to consider radiographic progression in RA patients who achieved in sustained clinical good response. The present study is to examine whether MRI findings at baseline are useful to predict subsequent radiographic progression in early-stage RA patients who achieves in sustained clinical good response.

Methods: This is a sub-analysis from the 1-year observational study from 76 early-stage RA patients recruited consecutively from Nagasaki University Early Arthritis Cohort in which the subjects received Gd-enhanced MRI of both wrists and finger joints. They gave their informed consent to be subjected to the protocol that was approved by the Institutional Review Board of Nagasaki University. All patients had been received DMARDs during 1 year after entry. The sustained clinical good response was defined by decrement of DAS28 ≥1.2 at 3 months as well as achievement of DAS28 remission through 6 months to 1 year. Synovitis, bone oedema and bone erosion determined by Gd-enhanced MRI were scored by OMERACT-RAMRIS. Plain radiographic damage was studied by Genant-modified Sharp score and the radiographic progression was defined as Δ progression > 0 at 1 year (Δ score > 0). We have investigated whether MRI findings are helpful to predict subsequent radiographic progression in the sustained clinical good responders.

Results: Twenty-four patients were classified as sustained clinical good responders and examined in the present study. Median age, disease duration were 56 y.o, 2.0 months and median DAS28-CRP, CRP (mg/dl), MMP-3 (ng/ml) were 4.40, 0.52 and 87.2, respectively. Rate of ACPA-positive and RF-positive were 91.7 and 83.3%. Median RAMRIS synovitis, bone edema, bone erosion score and Genant-modified Sharp score at baseline were 6, 0.5, 0 and 0, respectively. Among the 24 sustained clinical good responders, five patients developed radiographic progression at 1 year. Multivariate logistic regression analysis has identified that baseline RAMRIS bone erosion score (1 increase, Odds ratio 3.00, 95% C.I. 1.10-8.20�, p-value 0.032) is the only independent predictor toward the development of radiographic progression at 1 year. In addition, cut-off point 0.5 of baseline MRI bone erosion score showed the best discriminative value toward radiographic progression (sensitivity 100.0%, specificity 73.7%).

Conclusion: Our present data suggest that MRI bone erosion involves in subsequent radiographic progression of early-stage RA even successfully treated by treating RA to target (T2T) strategy. Physicians are recommended to pay attention to the presence of MRI bone erosion in these patients.


Disclosure: M. Tamai, None; Y. Nakashima, None; K. Arima, None; J. Kita, None; M. Umeda, None; S. Fukui, None; A. Nishino, None; T. Suzuki, None; Y. Horai, None; A. Okada, None; T. Koga, None; S. Y. Kawashiri, None; N. Iwamoto, None; K. Ichinose, None; S. Yamasaki, Eli Lilly K.K., 2; H. Nakamura, None; T. Origuchi, None; K. Aoyagi, None; M. Uetani, None; K. Eguchi, None; A. Kawakami, None.

To cite this abstract in AMA style:

Tamai M, Nakashima Y, Arima K, Kita J, Umeda M, Fukui S, Nishino A, Suzuki T, Horai Y, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Yamasaki S, Nakamura H, Origuchi T, Aoyagi K, Uetani M, Eguchi K, Kawakami A. MRI Bone Erosion at Baseline Predicts the Subsequent Radiographic Progression in Early-Stage RA Patients Who Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mri-bone-erosion-at-baseline-predicts-the-subsequent-radiographic-progression-in-early-stage-ra-patients-who-achieved-in-sustained-clinical-good-response-sub-analysis-from-nagasaki-university-early-a/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-bone-erosion-at-baseline-predicts-the-subsequent-radiographic-progression-in-early-stage-ra-patients-who-achieved-in-sustained-clinical-good-response-sub-analysis-from-nagasaki-university-early-a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology